Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Coherus Oncology (CHRS) Reports Q4 Loss, Misses Revenue Estimates
Coherus Oncology (CHRS) Reports Q4 Loss, Misses Revenue Estimates

Coherus Oncology (CHRS) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to a loss of $0.28 per share a year ago. These figures

Fluent (FLNT) Reports Q4 Loss, Misses Revenue Estimates
Fluent (FLNT) Reports Q4 Loss, Misses Revenue Estimates

Fluent (FLNT) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.18 per share a year ago. These figures are

Casey's General Stores (CASY) Beats Q3 Earnings Estimates
Casey's General Stores (CASY) Beats Q3 Earnings Estimates

Casey's General Stores (CASY) came out with quarterly earnings of $3.49 per share, beating the Zacks Consensus Estimate of $3.01 per share. This compares to earnings of $2.33 per share a year ago

CooperCompanies Insiders Buy as Rebound Setup Forms
CooperCompanies Insiders Buy as Rebound Setup Forms

CooperCompanies (NASDAQ: COO) insiders signaled confidence in the company’s growth outlook by buying shares in December, extending a trend that began the month before. Insiders, including the CEO

Septerna, Inc. (SEPN) Reports Q4 Loss, Tops Revenue Estimates
Septerna, Inc. (SEPN) Reports Q4 Loss, Tops Revenue Estimates

Septerna, Inc. (SEPN) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to a loss of $0.64 per share a year ago. These figures

Repay Holdings (RPAY) Lags Q4 Earnings Estimates
Repay Holdings (RPAY) Lags Q4 Earnings Estimates

Repay Holdings (RPAY) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.24 per share a year ago. These

LifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue Estimates
LifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue Estimates

LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.02 per share a year ago. These figures are

Vail Resorts (MTN) Q2 Earnings and Revenues Lag Estimates
Vail Resorts (MTN) Q2 Earnings and Revenues Lag Estimates

Vail Resorts (MTN) came out with quarterly earnings of $5.87 per share, missing the Zacks Consensus Estimate of $6.06 per share. This compares to earnings of $6.56 per share a year ago. These

Hewlett Packard Enterprise (HPE) Surpasses Q1 Earnings Estimates
Hewlett Packard Enterprise (HPE) Surpasses Q1 Earnings Estimates

Hewlett Packard Enterprise (HPE) came out with quarterly earnings of $0.65 per share, beating the Zacks Consensus Estimate of $0.59 per share. This compares to earnings of $0.49 per share a year

MacroGenics (MGNX) Reports Q4 Loss, Tops Revenue Estimates
MacroGenics (MGNX) Reports Q4 Loss, Tops Revenue Estimates

MacroGenics (MGNX) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to a loss of $0.25 per share a year ago. These figures are

Voyager Therapeutics (VYGR) Reports Q4 Loss, Beats Revenue Estimates
Voyager Therapeutics (VYGR) Reports Q4 Loss, Beats Revenue Estimates

Voyager Therapeutics (VYGR) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to a loss of $0.59 per share a year ago. These

Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates
Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates

Stereotaxis Inc. (STXS) came out with a quarterly loss of $0.06 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.09 per share a year ago. These figures are adjusted

Top Stock Reports for Visa, Chevron & Toyota Motor
Top Stock Reports for Visa, Chevron & Toyota Motor

Monday, March 9, 2026The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V),

Buy Hershey (HSY) Stock on the Dip for Defensive Safety?
Buy Hershey (HSY) Stock on the Dip for Defensive Safety?

Hershey’s HSY stock has seen a pullback from a 52-week high of $239 a share, which it hit after a strong Q4 report in February.

Nevertheless, Hershey shares have still soared more than 20% year to

2 Long Term Favorite Stocks Trading Near 52-Week Highs: https://staticx-tuner.zacks.com/images/articles/main/0c/139749.webp
2 Long Term Favorite Stocks Trading Near 52-Week Highs

When stocks are cruising near all-time or 52-week highs, it reflects considerable bullishness with trends where buyers are in control. Stocks making new highs tend to make even higher highs

Credo Technologies Hits Bottom: Now Is the Time to Buy
Credo Technologies Hits Bottom: Now Is the Time to Buy

While near-term headwinds persist, primarily in the form of investor concerns, Credo Technologies' (NASDAQ: CRDO) stock price is near its bottom and setting up for a rebound.

Concerns center

Amid Conflict Numerous Opportunities Arise in Stocks
Amid Conflict Numerous Opportunities Arise in Stocks

A combination of geopolitical tension, technological disruption fears, and financial market stress has created one of the most opportunity-rich environments I have seen in some time. The conflict

Up Over 50%: 3 Stocks on the Verge of a Massive Breakout in March
Up Over 50%: 3 Stocks on the Verge of a Massive Breakout in March

As March begins, investors might consider taking a more active role in selecting stocks by watching for potential breakout opportunities within specified price ranges. Under this approach, a stock

Do Options Traders Know Something About BMRN Stock We Don't?
Do Options Traders Know Something About BMRN Stock We Don't?

Investors in BioMarin Pharmaceutical Inc. BMRN need to pay close attention to the stock based on moves in the options market lately. That is because the March 20, 2026 $70 Put had some of the

Is the Options Market Predicting a Spike in Bank of Montreal Stock?
Is the Options Market Predicting a Spike in Bank of Montreal Stock?

Investors in Bank of Montreal BMO need to pay close attention to the stock based on moves in the options market lately. That is because the March 20, 2026 $60 Put had some of the highest implied

Are Money-Earning Games a Side Hustle or Just Entertainment?
Are Money-Earning Games a Side Hustle or Just Entertainment?
Gaming has evolved far beyond casual fun. Competitive tournaments, blockchain-based platforms, and app-based reward systems now promise financial returns for time spent playing. This shift has
5 High-Yield Stocks That Could Help Cushion Market Volatility
5 High-Yield Stocks That Could Help Cushion Market Volatility

As tensions in the Middle East continue to intensify and evolve rapidly, global equities are feeling the pressure. Energy markets have reacted quickly, with Brent crude surging above $100 per

Is Community Health Systems Attractive Despite Its Heavy Debt Load?
Is Community Health Systems Attractive Despite Its Heavy Debt Load?

Community Health Systems, Inc. CYH is a Franklin, TN-based operator of general acute care hospitals and outpatient facilities. The company is well-positioned for steady growth as demand for

3 Giants Across Sectors Lift Dividends 15% or More
3 Giants Across Sectors Lift Dividends 15% or More

Huge names across the financial, industrial, and technology sectors just announced dividend increases worth noting. The dividend boosts coming from these three firms aren’t run-of-the-mill; they

Reasons Why You Should Retain Veralto Stock in Your Portfolio Now: https://staticx-tuner.zacks.com/images/articles/main/4d/125239.webp
Reasons Why You Should Retain Veralto Stock in Your Portfolio Now

Veralto Corporation VLTO has an encouraging earnings surprise history, having surpassed the Zacks Consensus Estimate in each of the trailing four quarters, delivering an average surprise beat of